Craft

Advanced
Rexgenero

Rexgenero

Rexgenero Summary

Company Summary

Overview
Rexgenero is a regenerative medicine company developing cell-based therapeutics for the treatment of critical limb ischemia. It provides REX-001 immunotherapy built on the established biology of using cells from a patient’s own bone marrow.
Type
Private
Status
Active
Founded
2015
HQ
London, GB | view all locations
Website
https://rexgenero.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Joe Dupere

    Joe Dupere, Chief Executive Officer

    • Gaby Salem

      Gaby Salem, Non-Executive Director

      • Sadia L'Baouch

        Sadia L'Baouch, Vice President and Chief Manufacturing Officer

        LocationsView all

        3 locations detected

        • London, England HQ

          United Kingdom

          45 Pont St, Kensington

        • Sevilla, AL

          Spain

          Edificio Iris, Calle Max Planck, 3

        • Brighton, England

          United Kingdom

          Mocatta House, Trafalgar Terrace

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX